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Abstract
Inclusion body disease (IBD) is caused by reptarenaviruses and constitutes one of the most
notorious viral diseases in snakes. Although central nervous system disease and various
other clinical signs have been attributed to IBD in boid and pythonid snakes, studies that
unambiguously reveal the clinical course of natural IBD and reptarenavirus infection are
scarce. In the present study, the prevalence of IBD and reptarenaviruses in captive snake
collections and the correlation of IBD and reptarenavirus infection with the clinical status of
the sampled snakes were investigated. In three IBD positive collections, long-term follow-up
during a three- to seven-year period was performed. A total of 292 snakes (178 boas and
114 pythons) from 40 collections in Belgium were sampled. In each snake, blood and buffy
coat smears were evaluated for the presence of IBD inclusion bodies (IB) and whole blood
was tested for reptarenavirus RNA by RT-PCR. Of all tested snakes, 16.5% (48/292) were
positive for IBD of which all were boa constrictors (34.0%; 48/141) and 17.1% (50/292) were
reptarenavirus RT-PCR positive. The presence of IB could not be demonstrated in any of
the tested pythons, while 5.3% (6/114) were reptarenavirus positive. In contrast to pythons,
the presence of IB in peripheral blood cells in boa constrictors is strongly correlated with
reptarenavirus detection by RT-PCR (P<0.0001). Although boa constrictors often show per-
sistent subclinical infection, long-term follow-up indicated that a considerable number
(22.2%; 6/27) of IBD/reptarenavirus positive boas eventually develop IBD associated
comorbidities.
Introduction
Inclusion body disease (IBD) remains one of the most notorious viral diseases with a global
distribution in captive boid and pythonid snakes [1] and is characterized by the presence of
eosinophilic or amphophilic intracytoplasmic inclusion bodies (IB) in neurons and glial cells
from the central nervous system (CNS), epithelial cells from various organs, smooth muscle
tissue, lymphoid cells in esophageal tonsils and peripheral blood cells [2–5].
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Although the first study describing clinical signs in IBD positive (IBD+) snakes was pub-
lished in the early 1990s [6], the exact etiology of IBD remained enigmatic for almost two
decades. While retroviruses were initially proposed as candidate etiological agents of IBD [6–
9], it was not until recently that a causal relationship with novel divergent arenaviruses could
be demonstrated [4,5,10–14]. These negative-sense RNA viruses were classified as members of
the newly-formed genus Reptarenavirus, in the family Arenaviridae [15]. Based on a recent in
vivo experimental infection study, Koch’s postulates were fulfilled for a Golden reptarenavirus
(the type species of the genus, previously known as Golden Gate virus, GGV) as a causative
agent of IBD [5].
Inclusion body disease has been associated with the development of immunosuppression
[7,16] and a variety of clinical signs, such as anorexia, regurgitation, stomatitis, pneumonia,
lymphoproliferative disorders and CNS disease, have classically been associated with natural
reptarenavirus infection and IBD in snakes [1,2,6,7,17–20]. It remains unclear, however, what
primary clinical signs or comorbidities are truly associated with natural reptarenavirus infec-
tion and it seems to become more and more obvious that the disease may remain subclinical
or show a slowly progressive course in infected snakes [1,5]. The influence of reptarenaviruses
on the adaptive immune system of infected snakes has been studied and is likely to play an
important role in the disease progression and the development of comorbidities [21,22]. The
prevalence of reptarenavirus infection and IBD and the percentage of these asymptomatically
infected snakes that eventually will develop clinical signs as well as their role in the disease epi-
demiology, however, needs to be further elucidated [1,5].
The objectives of the present study were to determine the prevalence of IBD and reptarena-
virus infection in captive snake collections and to assess if the probability of the development
of comorbidities is related to IBD and reptarenavirus infection. In addition, long-term follow-
up of three IBD+ snake collections was performed and the agreement of IB detection in stained
blood and peripheral white blood cell (PWBC) smears as well as the agreement between IB
detection and the results of reptarenavirus RNA RT-PCR testing were evaluated.
Materials and methods
Ethics statement
Blood and tissue samples were collected through convenience sampling during entry control
testing, routine health assessments or the diagnostic work-up of snakes presented with clinical
signs at a veterinary teaching hospital. Blood and tissue samples were subjected to different
tests with the owners’ consent. The owners consented both to euthanasia and postmortem
sample collection in diseased snakes. No ethical permissions were required for the diagnosis-
motivated blood samplings, nor the euthanasia and diagnosis-motivated necropsies of sus-
pected IBD/reptarenavirus infected and diseased snakes (both routine veterinary purposes).
Animals and sample collection
During a three-year period, whole blood samples were collected from 292 captive boid (Boi-
dae) and pythonid (Pythonidae) snakes from 40 snake collections in Belgium (Table 1). Collec-
tions were categorized as closed or open based on the presence or absence of entry control and
providing a quarantine period for newly acquired snakes. In three of these collections long-
term follow-up of the clinical and IBD status was performed during a three-year period in one
collection (collection A) and a seven-year period in two collections (collections B and C),
respectively and sampling was performed annually. Collection A was an open and mixed col-
lection that included 85 boid snakes (35 boa constrictors/Boa constrictor, 45 reticulated
pythons/Malayopython reticulatus, two green anacondas/Eunectes murinus and three blood
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pythons/Python curtus) of which 10 boa constrictors and 10 reticulated pythons were repeat-
edly sampled. Collections B and C were closed collections, exclusively consisting of eight and
nine boa constrictors, respectively. Whole blood was obtained via cardiocentesis or ventral tail
venipuncture and transferred to K3E EDTA tubes (Microvette1 500 μL, Sarstedt) in all sam-
pled snakes.
Animal’s clinical status
General physical examination and assessment of the captive management was performed by
certified veterinarians (JS, TH) in all sampled snakes. In addition, oropharyngeal and cloacal
swabs were collected from all snakes for parasitological examination. Each snake was checked
for the presence of ectoparasites. In snakes that showed clinical signs, additional examinations,
Table 1. Results of inclusion body disease (IBD) and reptarenavirus infection testing in captive boid and pythonid snakes based on the detection of inclusion bodies
in hematoxylin and eosin stained blood smears and the detection of reptarenavirus via RT-PCR in blood samples.
IBD+ RT-PCR- IBD+ RT-PCR+ IBD- RT-PCR+ Subtotal IBD- RT-PCR- Total Sampled Snakes
Boidae
Acrantophis dumerili 0 0 0 0 9 9
A. madagascariensis 0 0 0 0 3 3
Boa constrictor 6 42 2 50 91 141
Calabaria reinhardtii 0 0 0 0 3 3
Candoia aspera 0 0 0 0 1 1
Corallus caninus 0 0 0 0 7 7
C. hortelanus 0 0 0 0 1 1
Epicrates cenchria 0 0 0 0 7 7
Eunectes murinus 0 0 0 0 1 1
Sanzinia madagascariensis 0 0 0 0 5 5
Subtotal Boidae 6 42 2 50 128 178
Relative (%) 3.4 23.6 1.1 28.1 71.9 100
Pythonidae
Bothrochilus albertisii 0 0 0 0 4 4
Malayopython reticulatus 0 0 0 0 25 25
Morelia spilota 0 0 1 1 3 4
M. viridis 0 0 0 0 7 7
Python bivittatus 0 0 1 1 3 4
P. breitensteini 0 0 1 1 3 4
P. brongersmai 0 0 0 0 4 4
P. curtus 0 0 1 1 4 5
P. molurus 0 0 0 0 8 8
P. regius 0 0 1 1 42 43
P. sebae 0 0 0 0 1 1
Simalia amethistina 0 0 0 0 3 3
S. clastolepis 0 0 1 1 1 2
Subtotal Pythonidae 0 0 6 6 108 114
Relative (%) 0 0 5.3 5.3 94.7 100
Total Sampled Snakes 6 42 8 56 236 292
Relative (%) 2.1 14.4 2.7 19.2 80.8 100
IBD+/-: inclusion bodies detected/not detected in hematoxylin and eosin stained whole blood or peripheral white blood cell smears. RT-PCR+/-: RT-PCR positive/
negative for reptarenavirus. RT-PCR, reverse transcriptase polymerase chain reaction.
https://doi.org/10.1371/journal.pone.0229667.t001
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such as medical imaging, microbiological testing and histopathological examination were per-
formed according to the observed disorder. Snakes were classified as clinically healthy (Ss-) or
diseased (Ss+) based on the absence or presence of clinical signs, respectively. Clinically dis-
eased snakes were further categorized based on the presence or absence of CNS disease
(opisthotonus, head tilt, incoordination, tremors, paralyses and delayed righting reflex).
Blood sample processing
Immediately following blood collection, blood smears were prepared for each sampled snake
on a microscopic glass slide (Menzel-Gla¨ser Superfrost1, Thermo Scientific) using standard
‘wedge’ techniques, air dried for 24 hours and H&E stained using a previously published pro-
tocol [12]. Next, peripheral white blood cell (PWBC) smears were prepared as previously
described by Chang et al. [1] In addition, a K3E EDTA whole blood sample was stored at
-21˚C until RT-PCR analysis.
Classification of IBD positive and IBD negative snakes
Snakes were classified as IBD positive (IBD+) or IBD negative (IBD-) based on the presence or
absence of characteristic IB in H&E stained blood smears and PWBC smears using light
microscopy with 1000x magnification. Smears were categorized as IBD- if no IB could be
detected following the inspection of at least 30 microscopic fields. As soon as a single blood
cell with a characteristic IBD inclusion body was detected, the sample was categorized as IBD+.
Reptarenavirus RNA detection by RT-PCR
The studied snakes were classified as reptarenavirus positive (RT-PCR+) or reptarenavirus
negative (RT-PCR-) based on the detection of reptarenavirus RNA via RT-PCR testing. RNA
was prepared from 200 μL of the thawed EDTA blood samples using a commercial kit
(MagNA Pure 96 DNA and viral NA small volume kit, Roche) according to the manufacturer’s
instructions. PCRs for the detection of reptarenaviruses were performed as a conventional
PCR using reagents from the RealTime ready RNA Virus Master kit (Roche, Mannheim, Ger-
many) as described previously with a mix of three forward primers (MDS-435: Arena-for1:
5'-TAT ACA ACC AAC GCC CTG TT -3', Arena-for2: 5'-TAC ACA ACC ACA GCC
CTG TT -3', Arena-for3: 5'-TAC ACA ACC ACA GCT CTG TT -3’) and two reverse
primers (MDS-436: Arena-rev1: 5’-AAC ACA TTG GGC CCT TCA C -3', Arena-rev2:
5'-AGC ACA TTG GGC CTT TTA C -3') [10,23]. Specific amplicons were 140 bp long.
Statistical data analysis
Snakes were categorized as IBD+ if IB were detected in H&E stained whole blood and PWBC
smears and were considered reptarenavirus infected if they were RT-PCR+. The overall preva-
lence of IBD and reptarenavirus infection was calculated by dividing the number of IBD+ and
RT-PCR+ snakes by the total number of individual snakes included in the study group, respec-
tively. The association between IBD/reptarenavirus infection and clinical signs, age, sex and
collection composition were investigated using Fisher’s exact test (clinical signs and collection
composition) and chi-square test (age and sex). The agreements between IB detection via
whole blood and PWBC H&E stained smears and the agreement between IB detection and the
presence of reptarenavirus RNA were assessed by calculating Cohen’s Kappa agreement and
using Fisher’s exact test. Kappa values 0, <0.4, 0.4–0.75, >0.75, and 1 were considered as no
agreement, poor agreement, good agreement, very good agreement, and perfect agreement,
respectively. Differences at P�0.05 were considered statistically significant. Statistical data
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analysis was performed using commercially available software (GraphPad Prism 5, GraphPad
Software).
Results
Study group
Samples were obtained from 292 snakes, comprising 114 pythons and 178 boas, belonging to
40 collections (Table 1). The average number of snakes per sampled collection and the average
percentage of sampled snakes per collection are depicted in Table 2. For each sampled snake,
the age and gender were recorded (Tables 3 & 4). Nine collections were considered as closed
collections (9/40) and 31 as open collections (31/40). In addition, collections were categorized
as exclusively comprising boas (13/40) or pythons (10/40) or as mixed collection (17/40).
Snake blood mite (Ophionyssus natricis) infestation was observed in 40.0% (16/40) collections
at the time of sampling.
Detection of inclusion bodies and reptarenavirus RNA
Inclusion bodies were exclusively found in boa constrictors (Table 1, Fig 1). The prevalence of
IBD+ snakes in the present study was 16.5% (48/292), including 27.0% (48/178) of the sampled
boas. Among boa constrictors, 34.0% (48/141) were IBD+. Reptarenavirus RNA was detected
in 17.1% (50/292) of the sampled snakes, including 44 boa constrictors and six pythons. In six
IBD+ boa constrictors, RT-PCR yielded negative results, while two IBD- boa constrictors were
RT-PCR+ in the present study. Sanger sequencing of the PCP products of the two IBD- boa
constrictors showed 100% identity of approximately 60 bp of the products with the corre-
sponding sequence of University of Giessen virus (GenBank MH503954.1). The overall preva-
lence of IBD and/or reptarenavirus infected snakes in the present study was 19.2% (56/292).
Among boa constrictors, a very good agreement was found between H&E stained whole
blood smears and PBWC smears for IB detection (Kappa agreement = 0.98; P<0.0001;
Table 5) as well as between IB detection in H&E stained smears and reptarenavirus RNA
detection via RT-PCR (Kappa agreement = 0.89; P<0.0001; Table 6).
Among the 50 IBD+ boa constrictors, 48.0% (24/50) were male, 42.0% (21/50) were female
while the sex was unknown in 10.0% (5/50; Table 3) and 10.0% (5/50) were juveniles, 32.0%
(16/50) were semi-adults and 58.0% (29/50) were adults (Table 4). Among the six RT-PCR+
pythons, two were male and four were female, of which two were juveniles (one Burmese
python/Python bivittatus and one ball python/Python regius), three were semi-adults (one car-
pet python/Morelia spilota, one blood python/P. curtus) and one Southern Moluccan python/
Simalia clastolepis) and one was an adult (Borneo python/Python breitensteini). Inclusion
body disease was not significantly associated with sex (P = 0.9796) or age (P = 0.5551).
Table 2. Number of sampled collections according to the collection size and the average percentage of snakes sam-
pled per collection size category.
Number of snakes per collection No˚ of collections Average % snakes sampled
3–5 14 100%
6–10 10 95%
11–20 4 70%
21–40 8 45%
41–60 2 30%
61 or more 2 20%
Total 40
https://doi.org/10.1371/journal.pone.0229667.t002
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Although a higher prevalence of IBD+ boa constrictors was observed in open and mixed collec-
tions in comparison to closed collections and collections exclusively consisting of boas, the dif-
ference was not statistically significant (P = 0.5751 and P = 0.5052, respectively).
Occurrence of clinical signs
Among the 292 snakes included in this study, 249 did not show clinical signs at the time of
sampling and 25 showed anorexia or regurgitation that could be unambiguously associated
with parasitic infection and/or inadequate husbandry conditions. The latter snakes were
excluded from the Ss+ group, provided that elimination of the clinical signs was seen following
antiparasitic treatment and/or optimization of husbandry. The Ss+ group of snakes included
15 boas and three pythons (Table 7). Of the Ss+ group, 12 snakes were IBD+ and exclusively
consisted of boa constrictors of which two boas were IBD+/RT-PCR-. The latter two snakes
were not included in the statistical analysis. Seven boa constrictors and three pythons showed
signs of CNS disease. While six out of seven of the latter boas were IBD+/RT-PCR+, the three
pythons were IBD-/RT-PCR-. The presence of clinical signs was significantly higher in IBD+/
RT-PCR+ snakes in comparison to IBD-/RT-PCR- snakes (P<0.0001).
Long-term follow-up
Collection A was an open and mixed collection consisting of 85, 91 and 82 snakes at the time
of sampling during the first, second and third year, respectively. Entry control and quarantine
were not performed and the collection was heavily infested with snake blood mites (Ophionys-
sus natricis) throughout the entire follow-up period. Repeated sampling was performed in the
same 10 boa constrictors and 10 reticulated pythons that were present at each annual sampling
Table 3. Relationship between inclusion body disease and reptarenavirus infection and sex in boas (Boidae) and pythons (Pythonidae).
Male Female Unknown Subtotal Total
IBD+ and/or RT-PCR+ Boas 24 21 5 50 56
Pythons 2 4 0 6
IBD- and RT-PCR- Boas 62 63 3 128 236
Pythons 51 40 17 108
Total 139 128 25 292
Positive male snakes: 18.7% (26/139); Positive female snakes: 19.5% (25/128); Sex unknown positive snakes: 20.0% (5/25). IBD+/-: inclusion bodies detected/not detected
in hematoxylin and eosin stained whole blood or peripheral white blood cell smears. RT-PCR+/-: RT-PCR positive/negative for reptarenavirus. RT-PCR, reverse
transcriptase polymerase chain reaction.
https://doi.org/10.1371/journal.pone.0229667.t003
Table 4. Relationship between inclusion body disease and reptarenavirus infection and age in boas (Boidae) and pythons (Pythonidae).
Juvenile Semi-adult Adult Subtotal Total
IBD+ and/or RT-PCR+ Boas 5 16 29 50 56
Pythons 2 3 1 6
IBD- and RT-PCR- Boas 29 37 62 128 236
Pythons 13 46 49 108
Total 49 102 141 292
Juvenile: 2 months to 1 year old, 14.3% (7/49) positive snakes; Semi-adult: 1 year to 5 years old, 18.6% (19/102) positive snakes; Adult: 5 years or older, 21.3% (30/141)
positive snakes. IBD+/-: inclusion bodies detected/not detected in H&E stained whole blood or peripheral white blood cell smears. RT-PCR+/-: RT-PCR positive/negative
for reptarenavirus. RT-PCR, reverse transcriptase polymerase chain reaction.
https://doi.org/10.1371/journal.pone.0229667.t004
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time point. In the first year, four boa constrictors were RT-PCR+ of which three were IBD+.
Although remaining RT-PCR+, no IB were found in the IBD-/RT-PCR+ boa during the entire
follow-up period. In the second year, one additional boa constrictor tested IBD+/RT-PCR+. In
the third year, test results were identical to those of the second year. All ten pythons remained
IBD-/RT-PCR- throughout the entire follow-up period. Initially, none of the tested snakes
showed clinical signs but in the third year, two IBD+/RT-PCR+ boa constrictors as well as
three IBD-/RT-PCR- reticulated pythons showed CNS disease signs. All of these latter snakes
were euthanized and brain and liver tissue were collected. Histopathological evaluation
revealed the presence of IB in hepatocytes of the boas. Although no IB were found in tissues
Fig 1. Inclusion body disease in a boa constrictor (Boa constrictor). Eosinophilic intracytoplasmic inclusion body in a
lymphocyte (arrow) in a hematoxylin and eosin stained blood smear from a reptarenavirus infected boa constrictor (Boa
constrictor). Occasionally, small eosinophilic intracytoplasmic inclusions were observed in heterophils (arrowhead) (1000x).
https://doi.org/10.1371/journal.pone.0229667.g001
Table 5. The agreement between hematoxylin and eosin stained whole blood and peripheral white blood cells
smears (PWBC) for the detection of inclusion bodies in boa constrictors (Boa constrictor).
Whole blood+ Whole blood- Total
PWBC+ 47 1 48
PWBC- 0 91 91
Total 47 92 139
Observed agreement: (47+91)/139 = 0.99
Kappa statistic = 0.98 (P<0.0001)
https://doi.org/10.1371/journal.pone.0229667.t005
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from the pythons, non-suppurative meningoencephalitis was diagnosed in all pythons. While
liver tissue was RT-PCR+ in all boas, brain tissue obtained from the boas and all tissues from
the pythons were RT-PCR-.
Collections B and C were closed collections, consisting of eight and nine boa constrictors,
respectively. In both collections the boas were housed individually, but males were temporarily
housed together with females during the breeding period. Snake blood mites were not
observed throughout the entire follow-up period. In collection B, four out of eight boa con-
strictors tested IBD+ in the first year, but only two tested RT-PCR+. Identical results were
obtained during seven consecutive years. One IBD+/RT-PCR+ boa was euthanized because of
progressive vertebral osteomyelitis in the 6th year, but no clinical signs were noticed in the
other boas during the entire follow-up period. During the sixth year, a IBD+/RT-PCR+ female
produced nine healthy neonates after mating with an IBD+/RT-PCR- male. The offspring
tested IBD-/RT-PCR- at the age of six, nine, and 12 months. In collection C, four out of nine
boa constrictors tested IBD+/RT-PCR+. Test results were identical during the entire follow-up
period. A colonic lymphoma was detected in one IBD+/RT-PCR+ boa during the fourth year
and another IBD+/RT-PCR+ boa developed an odontogenic fibromyxoma in the fifth year of
the follow-up period. In the latter boa, IB and reptarenavirus were detected in blood as well as
neoplastic and liver tissue as previously described by Hellebuyck et al. [19] In another IBD+/
RT-PCR+ boa, recurrent respiratory disease responsive to broad-spectrum antimicrobial treat-
ment was noted from the fourth until the last year of the follow-up period. In collection C, a
clutch of seven neonates from a IBD-/RT-PCR- female and a IBD+/RT-PCR+ male tested IBD-
and RT-PCR- at the age of eleven months.
Discussion
The overall prevalence of IBD and/or reptarenavirus infection in the present study was 19.2%
with a remarkably high prevalence of IBD in boa constrictors (34.0%). Although, a proportion-
ally larger number of boid species other than boa constrictors and pythonids tested reptarena-
virus positive in previous screening studies [1,21,24,25], the number of positive snakes that
were detected in these studies largely complies to our results. It should be noted, however, that
these studies focused on a smaller number of snakes belonging to a single (zoological) collec-
tion [21,24,25] or a more limited number of snake collections [1].
In the present study, clinical signs were seen in 25.0% (12/48) of the IBD+ snakes, exclu-
sively consisting of boa constrictors, and included bacterial vertebral osteomyelitis, recurrent
respiratory disease, neoplastic disorders and CNS disease. Based on our results, these clinical
signs may be considered as comorbidities that are significantly associated with IBD/
Table 6. The agreement between inclusion body detection in hematoxylin and eosin stained blood and peripheral
white blood cells smears and the detection of reptarenavirus RNA by reverse transcriptase polymerase chain reac-
tion (RT-PCR) in blood samples in boa constrictors (Boa constrictor).
IBD+ IBD- Total
RT-PCR+ 42 2 44
RT-PCR- 6 91 97
Total 48 93 141
Observed agreement: (42+91)/141 = 0.94
Kappa statistic = 0.89 (P<0.0001)
IBD+/-: inclusion bodies detected/not detected in hematoxylin and eosin stained whole blood or peripheral white
blood cell smears. RT-PCR+/-: RT-PCR positive/negative for reptarenavirus.
https://doi.org/10.1371/journal.pone.0229667.t006
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reptarenavirus infection in snakes (P<0.0001). Although immunocompromised snakes may
be more susceptible to reptarenavirus infection, the development of comorbidities as observed
in this study may also be facilitated by the immunosuppression resulting from arenavirus
infection as previously described in other animals with arenavirus infection [26] and recently
in reptarenavirus infected boa constrictors [21]. As previously reported [1,24,25], it should be
noted that many boa constrictors showed subclinical infections at the moment of sampling
and although long-term follow-up was based on a sampling of a limited number of collections,
our findings indicate that it may take several years before infection becomes clinical in IBD+
or reptarenavirus infected snakes.
A recent study confirmed that pythons rapidly develop CNS disease following experimental
inoculation with a reptarenavirus [5]. While no IBD inclusions were found in H&E stained
blood smears and PWBC smears and tissue sections, non-suppurative meningoencephalitis
was observed in histologic sections from the three pythons from collection A that showed CNS
disease indicating viral infection, but an exact etiology could not be demonstrated. Although it
remains possible that some reptarenaviruses were not detected by the RT-PCR used in this
study, various other infectious but also non-infectious causes may be associated with CNS dis-
ease and associated histopathological findings [1,13,27,28,29] as observed in the three pythons
from collection A that showed CNS disease. The relatively low number of reptarenavirus
infected pythons in our study and the absence of clinical signs in these pythons is a noteworthy
finding, especially taking into account the considerable number of sampled mixed collections
that included IBD+/RT-PCR+ boa constrictor and mostly lacked preventive measures against
the introduction and transmission of reptarenaviruses. Moreover, many of these collections
were heavily infested with snake blood mites which are considered potential vectors of reptare-
naviruses [2,16,30]. Importantly, it should be noted that in the present study, with the exception
of the euthanized snakes included in the long-term follow-up of collection A, testing for IB and
reptarenavirus was limited to blood samples and routinely available diagnostic methods.
Accordingly, the true prevalence of IBD and reptarenavirus infection may be underestimated,
especially in the sampled pythons, as it is generally accepted that IB and reptarenaviruses may
be confined to the CNS in pythons [5]. The use of other diagnostic testing modalities such as
immunohistochemical (IHC) staining could have increased the sensitivity and specificity
towards the detection of reptarenavirus nucleoprotein in blood smears and samples collected
for histopathological examination [1,12] and IBD detection in early infection stages [4].
Although recent studies of the snake adaptive immune response to reptarenavirus infection in
Table 7. Association between the presence of inclusion bodies disease and/or reptarenavirus infection with clinical signs in boas (Boidae) and pythons
(Pythonidae).
IBD+ RT-PCR- IBD+ RT-PCR+ IBD- RT-PCR+ Subtotal IBD- RT-PCR- Subtotal Total
B P B P B P B P
Ss+ Respiratory disease 1 0 1 0 0 0 2 1 0 1 3
Neoplasia 0 0 2 0 0 0 2 0 0 2 2
Vertebral osteomyelitis 1 0 1 0 0 0 2 1 0 1 3
Central nervous system disease 0 0 6 0 0 0 6 1 3 4 10
Subtotal 2 0 10 0 0 0 12 3 3 6 18
Ss- 4 0 32 0 2 6 44 125 105 230 230
Total 6 0 42 0 2 6 56 128 108 236 292
IBD+/-: inclusion bodies detected/not detected in hematoxylin and eosin stained whole blood or peripheral white blood cell smears. RT-PCR+/-: RT-PCR positive/
negative for reptarenavirus. Ss+/-: clinical symptoms observed/not observed. B, boas (Boidae). P, pythons (Pythonidae). RT-PCR, reverse transcriptase polymerase chain
reaction.
https://doi.org/10.1371/journal.pone.0229667.t007
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boa constrictors demonstrated inconsistency in anti-reptarenavirus antibody formation in
infected snakes [22] and an apparent negative correlation between IBD and anti-reptarenavirus
antibodies [21], serological testing could be attempted to detect (non-viraemic) reptarenavirus
infection [21]. The use of oral and cloacal swabs as well as sampling of the esophageal tonsils for
RT-PCR testing has been described and could increase the sensitivity of reptarenavirus infection
testing in combination with other testing modalities [24,25]. More research is needed to assess
the sole or adjuvant diagnostic value of these diagnostic methods in the antemortem diagnosis
of reptarenavirus infection in boid and pythonid snakes.
In contrast to what has been described by Hyndman et al. [24], serial testing performed
during the long-term follow-up of three collections did not reveal considerable changes in the
number of IBD+ or RT-PCR+ snakes that were detected. It should be mentioned that boa con-
strictors were overrepresented in the collections that were subjected to long-term follow-up,
while Hyndman et al. [24] mainly performed testing in pythons. Based on the methods used in
this study, vertical transmission of reptarenaviruses as described by Keller et al. [4] and Aqrawi
et al. [23] could not be demonstrated through testing of juvenile boa constrictors from collec-
tions B and C. In the study of Keller et al. [4], IB as well as reptarenavirus RNA could be
detected at an age of eight months in blood samples obtained from juvenile boas that were ver-
tically infected. For this reason, the likelihood of demonstrating vertical transmission in the
offspring from an IBD+/RT-PCR- father and IBD+/RT-PCR+ mother of collection B that was
tested at an age of nine and 12 months and the offspring from an IBD+/RT-PCR+ father and
IBD-/RT-PCR- mother of collection C tested at an age of 11 months was deemed to be consid-
erably high based on the performed IB and RT-PCR testing. It should be taken into account
that vertical transmission might not have occurred in the tested offspring of collection C if the
mother was not infected with reptarenavirus during co-habitation and mating with the IBD+/
RT-PCR+ father. As previously discussed, however, reptarenaviruses can escape RT-PCR
detection and this could have contributed to the obtained negative results in the tested off-
spring from both collections [1]. Besides serial testing of the offspring from collection B during
a prolonged time period, postmortem sample collection (including brain tissue) for IB detec-
tion based on H&E and/or IHC staining as well as reptarenavirus RT-PCR might have pro-
vided more certainty towards the occurrence of vertical transmission in the tested juvenile
boas [4,23].
A very good agreement was found for IB detection in blood smears compared to detection
in PWBC as well as between the presence of IB and the detection of reptarenavirus in blood
samples from boa constrictors. No IB were detected in any of the sampled pythons in this
study, supporting the findings of former studies indicating that reptarenavirus infected
pythons do not routinely develop IB in circulating blood cells [1,5,24,25]. In addition, IB were
not detected in blood and PWBC smears of two RT-PCR+ boas, suggesting that similar to
pythons, the absence of IB does not rule out reptarenavirus infection in boa constrictors, espe-
cially in the earliest stage of reptarenavirus infection and in vertically infected neonatal snakes
[4,5,25]. The fact that several IBD+ boa constrictors consistently tested RT-PCR- (collection B)
is remarkable. Although it cannot be fully excluded, it is very unlikely that the detection of IB
in IBD+/RT-PCR- boas was unrelated to reptarenavirus infection as these IB had the typical
appearance of IBD inclusions in H&E stained smears [3,12,13,24,25,31] identical to those
found in IBD+/RT-PCR+ boas in the present study. As previously reported, however, reptare-
naviruses are highly genetically diverse [3,4,14] and although the RT-PCR that was applied in
the present study has a high sensitivity comparable to a similar PCR that allowed the detection
of a wide range of reptarenaviruses [3] and has been used to detect reptarenaviruses in a large
variety of boid and pythonid snakes and vipers [23], it is possible that some RT-PCR- results
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might have been false negatives as some reptarenaviruses might escape detection by RT-PCR
due to mutations in the primer binding regions [3,4,13,14,24].
Conclusion
The results of this large-scale study demonstrate that IBD and reptarenaviruses are highly
prevalent in captive boa constrictors and that both boas as well as pythons can act as asymp-
tomatic carriers of reptarenaviruses. The presence of IBD+/RT-PCR+ boa constrictors does not
seem to contribute to increased IBD associated morbidity at the level of a collection, but a con-
siderable number of chronically IBD+ boa constrictors seem to eventually develop IBD/reptar-
enavirus associated comorbidities. Our findings suggest that evaluation of H&E stained blood
and PWBC smears combined with RT-PCR testing of blood samples have an excellent predic-
tive value towards the diagnosis of IBD/reptarenavirus infection in semi-adult and adult boa
constrictors. In pythons and in early reptarenavirus infection stages, however, results of ante-
mortem diagnosis based on these methods should be cautiously interpreted as IB and reptare-
navirus RNA do not seem to be readily detected in blood samples.
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